Alkermes Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IE00B56GVS15
USD
49.17
0.8 (1.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Jazz Pharmaceuticals Plc
Exelixis, Inc.
Neurocrine Biosciences, Inc.
Intra-Cellular Therapies, Inc.
United Therapeutics Corp.
Repligen Corp.
Catalent, Inc.
Ionis Pharmaceuticals, Inc.
Alkermes Plc
Roivant Sciences Ltd.
Karuna Therapeutics, Inc.

Why is Alkermes Plc ?

1
The company has declared negative results for the last 3 consecutive quarters
  • PRE-TAX PROFIT(Q) At USD 24.54 MM has Fallen at -51.89%
  • OPERATING CASH FLOW(Y) Lowest at USD 251.18 MM
  • ROCE(HY) Lowest at 3.85%
2
With ROE of 13.28%, it has a expensive valuation with a 2.75 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 82.18%, its profits have fallen by -35.2%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Alkermes Plc for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Alkermes Plc
84.88%
2.31
43.26%
S&P 500
22.36%
1.63
13.19%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
7.28%
EBIT Growth (5y)
33.62%
EBIT to Interest (avg)
3.19
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.58
Sales to Capital Employed (avg)
0.97
Tax Ratio
15.79%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
21.80%
ROE (avg)
12.43%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
2.75
EV to EBIT
14.55
EV to EBITDA
13.15
EV to Capital Employed
7.29
EV to Sales
2.50
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
50.13%
ROE (Latest)
13.28%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
NET SALES(Q)

Highest at USD 496.01 MM

-25What is not working for the Company
PRE-TAX PROFIT(Q)

At USD 24.54 MM has Fallen at -51.89%

OPERATING CASH FLOW(Y)

Lowest at USD 251.18 MM

ROCE(HY)

Lowest at 3.85%

RAW MATERIAL COST(Y)

Grown by 13.56% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 50.65 %

INTEREST(Q)

Highest at USD 25.93 MM

NET PROFIT(Q)

At USD 26.92 MM has Fallen at -29.5%

Here's what is working for Alkermes Plc

Net Sales
Highest at USD 496.01 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Net Sales
At USD 496.01 MM has Grown at 26.99%
over average net sales of the previous four periods of USD 390.57 MM
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Depreciation
Highest at USD 30.28 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Depreciation
At USD 30.28 MM has Grown at 55.83%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (USD MM)

Here's what is not working for Alkermes Plc

Pre-Tax Profit
At USD 24.54 MM has Fallen at -51.89%
over average net sales of the previous four periods of USD 51.01 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Interest
At USD 25.93 MM has Grown at 24.09%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Cash Flow
Lowest at USD 251.18 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Interest
Highest at USD 25.93 MM
in the last five periods and Increased by 24.09% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Net Profit
At USD 26.92 MM has Fallen at -29.5%
over average net sales of the previous four periods of USD 38.18 MM
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

Debt-Equity Ratio
Highest at 50.65 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 13.56% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales